Approach to Mycosis Fungoides in children: Consensus-based recommendations

Alex Zvulunov, Holly Neale, Jonah Stern, Pasqualina Santaguida, Amy Buros Stein, Mark Koh, Lawrence F. Eichenfield, Joan Guitart, Matthias Goebeler, Julia Scarisbrick, Rein Willemze, Carrie C. Coughlin, Renu George, Valeria Brazzelli, Márta Marschalkó, Irena Belousova, Christiane Querfeld, Martine Bagot, Jacek C. Szepietowski, Evangelina PapadavidPietro Quaglino, Peter Hoeger, Pablo L. Ortiz-Romero, Vasiliki Nikolaou, Reinhard Dummer, Phyu P. Aung, Leslie Lawley, Kimberly D. Morel, Bo Ngan, Mary Wain, Ana Gameiro, Rosa María Lacy-Niebla, Elena Pope

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Pediatric Mycosis fungoides (MF) management extrapolates from adult guidelines, despite differing clinical aspects. Recommendations are essential to address unique challenges in this distinct patient group. Objective: This project aims to derive consensus recommendations for pediatric MF management. Methods: Experts from pediatric dermatology, general dermatology, dermatopathology, and pediatric hematology-oncology (N = 83) were invited to contribute to consensus recommendations. The process involved 3 electronic Delphi rounds, concluding with a final consensus meeting using a modified Nominal Group Technique for unresolved items. Results: Consensus included more clinical severity measures than tumor-node-metastasis-blood staging: pruritus, functional or esthetic impairment (eg, palms, soles, genitalia), quality of life impact, and psychological aspects (eg, embarrassment, anxiety, depression), plus parental anxiety. Ten recommendations were made for managing early and advanced pediatric MF. Disagreement emerged in choosing therapies beyond stage I of the disease. Discussion: This multinational initiative aimed to standardize optimal pediatric MF management and successfully generated consensus recommendations. Additional work is needed for structured, prospective protocols in advanced-stage pediatric MF. Limitations: Lack of pediatric hematologists-oncologists and patients' representatives. Conclusion: Documentation of extended clinical severity and outcome measures is recommended. Addressing the need for structured protocols in advanced-stage pediatric MF and implementing systematic, prospective data collection is crucial.

Original languageEnglish
Pages (from-to)1078-1085
Number of pages8
JournalJournal of the American Academy of Dermatology
Volume91
Issue number6
DOIs
StatePublished - Dec 2024

Keywords

  • consensus
  • mycosis fungoides
  • pediatric
  • severity and outcome measures

Fingerprint

Dive into the research topics of 'Approach to Mycosis Fungoides in children: Consensus-based recommendations'. Together they form a unique fingerprint.

Cite this